Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | INCB057643 |
Synonyms | |
Therapy Description |
INCB057643 is an inhibitor of proteins containing BET bromodomains, which potentially reduces tumor growth (PMID: 29567272, PMID: 31527168, PMID: 31402217). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
INCB057643 | INCB57643|INCB 057643|INCB-057643 | BET Inhibitor (Pan) 32 | INCB057643 is an inhibitor of proteins containing BET bromodomains, which potentially reduces tumor growth (PMID: 29567272, PMID: 31527168, PMID: 31402217). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02711137 | Phase Ib/II | INCB057643 | A Phase 1/2, Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies | Terminated | USA | FRA | BEL | 0 |
NCT04279847 | Phase I | INCB057643 | Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms (LIMBER) | Recruiting | USA | NLD | ITA | GBR | FIN | ESP | CAN | 1 |